Literature DB >> 17008478

Caring for the burden of COPD.

P M A Calverley.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17008478      PMCID： PMC2104772          DOI： 10.1136/thx.2006.060855

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  27 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  Audit of acute admissions of COPD: standards of care and management in the hospital setting.

Authors:  C M Roberts; I Ryland; D Lowe; Y Kelly; C E Bucknall; M G Pearson
Journal:  Eur Respir J       Date:  2001-03       Impact factor: 16.671

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  M M Cotton; C E Bucknall; K D Dagg; M K Johnson; G MacGregor; C Stewart; R D Stevenson
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

5.  Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: Effect of age related factors and service organisation.

Authors:  M J Connolly; D Lowe; K Anstey; H S R Hosker; M G Pearson; C M Roberts
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

6.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Peter Calverley; Romain Pauwels; Jørgen Vestbo; Paul Jones; Neil Pride; Amund Gulsvik; Julie Anderson; Claire Maden
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

7.  Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.

Authors:  P M A Calverley; A Lee; L Towse; J van Noord; T J Witek; S Kelsen
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

8.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

Authors:  J Garcia-Aymerich; E Farrero; M A Félez; J Izquierdo; R M Marrades; J M Antó
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

9.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

10.  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors: 
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139
View more
  1 in total

1.  Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients.

Authors:  Colin R Simpson; Julia Hippisley-Cox; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2010-07       Impact factor: 5.386
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.